For help on how to get the results you want, see our search tips.
6 results
Medicine
Shortages Remove Shortages filter
Summaries of opinion Remove Summaries of opinion filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Withdrawn applications Remove Withdrawn applications filter
Medicine type
Orphan medicine Remove Orphan medicine filter
Biosimilar Remove Biosimilar filter
Conditional approval Remove Conditional approval filter
Withdrawal type
Post-authorisation Remove Post-authorisation filter
Categories
Human Remove Human filter
-
List item
Withdrawn application: Bylvay (updated)
odevixibat, date of withdrawal: 22/10/2023, Post-authorisation, Last updated: 23/11/2023 -
List item
Withdrawn application: Gazyvaro
obinutuzumab, date of withdrawal: 04/07/2023, Post-authorisation, Last updated: 04/10/2023 -
List item
Withdrawn application: Gavreto
pralsetinib, date of withdrawal: 03/11/2022, Post-authorisation, Last updated: 02/02/2023 -
List item
Withdrawn application: Imcivree
setmelanotide, date of withdrawal: 22/04/2022, Post-authorisation, Last updated: 28/09/2022 -
List item
Withdrawn application: Opsumit
macitentan, date of withdrawal: 08/11/2019, Post-authorisation, Last updated: 17/02/2020 -
List item
Withdrawn application: Translarna
ataluren, date of withdrawal: 06/03/2017, Post-authorisation, Last updated: 24/03/2017